S. Forman Mark's Insider Trades & SAST Disclosures
S. Forman Mark's most recent trade in Passage Bio Inc was a trade of 203,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern S. Forman Mark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Passage Bio Inc | Mark S. Forman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 203,000 | 203,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Forman S. Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | Forman Mark S. | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 50,000 | 61,082 (0%) | 0% | - | Common Stock | |
| Passage Bio Inc | Mark Forman S. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 31 Dec 2023 | 15,813 | 45,269 (0%) | 0% | 0.9 | 14,390 | Common Stock |
| Passage Bio Inc | Mark S. Forman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Mark S. Forman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | Mark S. Forman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 136,000 | 136,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Mark S. Forman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 136,000 | 136,000 | - | - | Employee Stock Options (right to buy) | |
| Passage Bio Inc | S. Mark Forman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | S. Mark Forman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Mark S. Forman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | Forman Mark S. | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 5,000 | 50,269 (0%) | 0% | - | Common Stock | |
| Passage Bio Inc | S. Forman Mark | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 5,000 | 10,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | S. Mark Forman | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 16 Aug 2021 | 1,638 | 48,631 (0%) | 0% | 1.0 | 1,589 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges